| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Biomimetic tissues on a chip for drug discovery
|
Ghaemmaghami, Amir M.
|
|
2012
|
17 |
3-4 |
p. 173-181
9 p.
|
artikel
|
| 2 |
Contents
|
|
|
2012
|
17 |
3-4 |
p. i-
1 p.
|
artikel
|
| 3 |
Contents
|
|
|
2012
|
17 |
3-4 |
p. iii-
1 p.
|
artikel
|
| 4 |
Effective pharmaceutical regulation needs alignment with doctors
|
Ebbers, Hans C.
|
|
2012
|
17 |
3-4 |
p. 100-103
4 p.
|
artikel
|
| 5 |
Fetal hypoxia and programming of matrix metalloproteinases
|
Tong, Wenni
|
|
2012
|
17 |
3-4 |
p. 124-134
11 p.
|
artikel
|
| 6 |
Liposomal drug formulations in cancer therapy: 15 years along the road
|
Slingerland, Marije
|
|
2012
|
17 |
3-4 |
p. 160-166
7 p.
|
artikel
|
| 7 |
Mesopore-assisted profiling strategies in clinical proteomics for drug/target discovery
|
Savino, Rocco
|
|
2012
|
17 |
3-4 |
p. 143-152
10 p.
|
artikel
|
| 8 |
MRI as a tool for evaluation of oral controlled release dosage forms
|
Dorożyński, Przemysław P.
|
|
2012
|
17 |
3-4 |
p. 110-123
14 p.
|
artikel
|
| 9 |
Rare disease patient groups as clinical researchers
|
Polich, Ginger R.
|
|
2012
|
17 |
3-4 |
p. 167-172
6 p.
|
artikel
|
| 10 |
Retrospective clinical analysis for drug rescue: for new indications or stratified patient groups
|
Cavalla, David
|
|
2012
|
17 |
3-4 |
p. 104-109
6 p.
|
artikel
|
| 11 |
The formulation of polyhedral boranes for the boron neutron capture therapy of cancer
|
Calabrese, Gianpiero
|
|
2012
|
17 |
3-4 |
p. 153-159
7 p.
|
artikel
|
| 12 |
The routes to orphan drug designation – our recent experience at the FDA
|
Lev, Daniel
|
|
2012
|
17 |
3-4 |
p. 97-99
3 p.
|
artikel
|
| 13 |
The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries
|
Modi, Sandeep
|
|
2012
|
17 |
3-4 |
p. 135-142
8 p.
|
artikel
|
Tijdschrift beschrijving